Drug-eluting stents for the prevention of restenosis: In quest for the holy grail

Catheterization and Cardiovascular Interventions

Volumn 55, Issue 3, 2002, Pages 409-417

  Hiatt, Bonnie L ^a   Ikeno, Fumaiki ^a   Yeung, Alan C ^a   Carter, Andrew J ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Providence Heart Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; DACTINOMYCIN; PACLITAXEL; PACLITAXEL DERIVATIVE; RAPAMYCIN;

ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CORONARY STENT; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG MECHANISM; HEART MUSCLE REVASCULARIZATION; HUMAN; NONHUMAN; RESTENOSIS;

ANIMALS; CELL DIVISION; CLINICAL TRIALS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY RESTENOSIS; DACTINOMYCIN; DEPRESSION, CHEMICAL; HUMANS; INFUSION PUMPS, IMPLANTABLE; MUSCLE, SMOOTH, VASCULAR; PACLITAXEL; SIROLIMUS; STENTS;

EID: 0036195346     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10161     Document Type: Article

References (29)

1. Percutaneous coronary intervention in the current era compared with 1985-1986: The national heart, lung, and blood institute registries
2. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome
3. In-stent restenosis: The great equalizer - Disappointing clinical outcomes with all interventional strategies
4. Beta radiation to Inhibit recurrance of in-stent restenosis: Clinical and angiographic results of the multicenter randomized double blind study
5. The beta-cath system trial
6. Patterns and mechanisms of in-stent restenosis: Serial intravascular ultrasound study
7. In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia
8. Identification of a new pharmacologic action for an old compound
9. Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury: Its effect on cellular, growth factor, and cytokine response in injured vessels
10. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells
11. Rapamycin inhibits vascular smooth muscle cell migration
12. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle
13. Paclitaxel (taxol)
14. Micotubules
15. Promotion of microtubule assembly in vitro by taxol
16. Taxol stabilizes microtubules in mouse fibroblast cells
17. cdc2 coincident with Taxol-induced apoptosis
18. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat
19. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery
20. Neointimal thickening after stent delivery of paclitaxel: Change in composition and arrest of growth over 6 months
21. Inhibition of in-stent restenosis by the quanam drug eluting polymer stent: Two year follow-up
22. Newer immunosuppressive drugs: A review
23. Chemistry and biology of the immunophilins and their immunosuppressive ligands
24. Stent-based delivery of sirolimus for the prevention of restenosis
25. Stent based sirolimus delivery reduces neointimal proliferation in a porcine coronary model of restenosis
26. Temporal effects on arterial repair of a sustained release formulation of sirolimus eluting from a stent
27. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis
28. Pathological analysis of local delivery of paclitaxel via a polymer- coated stent
29. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study